Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

06. Mars 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1918


	Articles 1 - 20 / 38358

	First-Line Serplulimab versus Other Anti-PD-1/PD-L1 Antibodies Plus Chemotherapy for Esophageal Squamous Cell Carcinoma: A Systematic Review with Benefit-Risk Assessment via Matching-Adjusted Indirect Comparison. Biologics Zhu Y, Qi X, Ni S, Qiu W, Chen M. PMID: 41788456 [PubMed]
	Prognostic Impact of Postoperative Complications After Neoadjuvant Therapy Followed by Esophagectomy for Esophageal Cancer: An Exploratory Analysis of Phase III Trial JCOG1109. Ann Surg Booka E, Kato K, Ito Y, Daiko H, Koyanagi K, Yamamoto M, Ogata T, Fukuda T, Fujita T, Abe T, Takahashi M, Watanabe M, Ichikawa H, Hihara J, Kanda M, Hamai Y, Tsushima T, Machida R, Sasaki K, Takeuchi H. PMID: 41787642 [PubMed - as supplied by publisher]
	Preoperative risk factors for postoperative physical frailty in patients with esophageal cancer: a scoping review. Esophagus Toyama S, Suzuki K, Yanagisawa T, Nakagami T, Ikeda T, Himematsu H, Fukushima T, Sato H, Okura K, Tsuji T, Harada T. PMID: 41787201 [PubMed - as supplied by publisher]
	A longitudinal CT-based subregional radiomics nomogram for predicting local recurrence-free survival in esophageal squamous cell carcinoma after definitive chemoradiotherapy: a multicenter study. Radiother Oncol Gong J, Yang Z, Li J, Wang Q, Meng F, Liu M, Sun H, Zhao L. PMID: 41786222 [PubMed - as supplied by publisher]
	ISDE guidelines on the management of cT2N0 esophageal cancer. Dis Esophagus Kohn GP, Litle V, Eliya Y, Leng S, Asghari-Jafarabadi M, Contreras N, Davies A, Lackner R, Mak KS, Mala T, Markman B, Mukherjee S, Nevala-Plagemann C, Smyth E, Sultan J, Worrell S, Yamamoto S, Wijnhoven BPL, Griffiths EA. PMID: 41785274 [PubMed - in process]
	SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025). Clin Transl Oncol Fernández-Montes A, Alcaide J, Custodio AB, Fernández Franco L, Gallego Plazas J, Gómez-Martín C, Richart P, Rivera F, Alsina M. PMID: 41784706 [PubMed - as supplied by publisher]
	A pragmatic phase II trial evaluating treatment strategies using immune checkpoint inhibitors for metastatic esophageal cancer patients with severe dysphagia. ESMO Gastrointest Oncol Nagata Y, Arai H, Izawa N, Inagaki C, Sugaya A, Hirata K, Tsushima T, Moriwaki T, Masuishi T, Nagatani Y, Harada K, Taguri M, Sunakawa Y. PMID: 41783111 [PubMed]
	Minimally invasive or open esophagectomy for esophageal squamous cell carcinoma: a comprehensive systematic review of surgical and survival outcomes. Front Surg Barnawi AB, Hajjar WM, Almaymuni AD, Alzahim A, Al-Ahmari OT, Alshahrani B, Aljanoubi A, Bukhari LR, Alsharari MS, Al-Sahli MA, Bin Kassim AA, Alodayani A. PMID: 41782915 [PubMed]
	A Systematic Review of Inflatable Transcervical Mediastinoscopic Oesophagectomy and McKeown Oesophagectomy in Oesophageal Cancer. J Coll Physicians Surg Pak Onyebuchi IC, Zhu S, Qi Y, Hou G. PMID: 41781833 [PubMed - in process]
	Retrospective population-based cohort study on the risk of cardiovascular disease among oesophageal cancer survivors. Br J Surg Kim S, Han KD, Jung J, Song YM, Park JH, Cho JH, Shin DW. PMID: 41779631 [PubMed - in process]
	Precision palliative care in advanced/recurrent esophageal cancer patients treated with anti-PD-1/PD-L1 immunotherapy (ESO-Shanghai 25): a randomized, phase III Trial. Future Oncol Hao S, Wang X, Ding H, Chen Y, Liu Q, Zhang J, Fan X, Wu Z, Lin Y, Xu X, Mao G, Ai D, Deng J, Zhu H, Ye J, Mo M, Hu Z, Wang H, Cheng W, Feng W, Ling Y, Xu Y, Du S, Wang J, Zhao K. PMID: 41778625 [PubMed - as supplied by publisher]
	An Extracellular Vesicle Protein-Based Machine Learning Framework for Early Detection of Oesophageal Squamous Cell Carcinoma: A Multicentre, Prospective Study. J Extracell Vesicles Wang Y, Xing S, Wu YX, Xue N, Chen PM, Jin RX, Xu YW, Ji MF, Peng YH, Liu YT, Chen LN, Wu M, Jiang ZY, Xie SH, Luo YL, Zhang B, Ou XY, Huang Q, Tian BY, Ling L, Cao SM, Liu WL, Zeng MS, Zhong Q. PMID: 41777088 [PubMed - in process]
	Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trial. BMC Med Chen Z, Li W, Guo Y, Zhu Y, Song Y, Wu J, Zheng W, Tseng Y, Lin L, Tang F, Mao B, Zhao P, Guo X, Fu S, Chen G, Wu N, Lv B, Liu Y, Zhao S, Mo S, Ma K, Fu K, Zhang H, Zhang J, Luo F, Luo Z, Liu J. PMID: 41776515 [PubMed - as supplied by publisher]
	Technical feasibility and outcomes of endoscopic submucosal dissection for superficial esophageal cancer in diverticula: a case series study (with video). Surg Endosc Zhang C, Dou L, Zhang Y, Liu Y, Cai A, Zha B, He S, Wang G. PMID: 41776096 [PubMed - as supplied by publisher]
	Corrigendum to "Efficacy of Oxycodone Combined With Thoracic Paravertebral Nerve Block for Postoperative Analgesia in Esophageal Cancer Surgery: A Retrospective Study". Ann Pharmacother PMID: 41773723 [PubMed - as supplied by publisher]
	Effects of Depression and Anxiety on Survival Prognosis Among Individuals With Gastric and/or Esophageal Cancer: Systematic Review and Meta-Analysis. Psychooncology Bayati R, Hatami H, Panahi MH. PMID: 41773323 [PubMed - in process]
	A meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally resectable esophageal cancer based on RCTs. Front Oncol Xu T, Wang L, Zhang X, Yu X, Zhang S, Zheng J, Fei J. PMID: 41768228 [PubMed]
	Development and Validation of a Nomogram Based on Advanced Lung Cancer Inflammation Index for Predicting Overall Survival in Non-Surgical Esophageal Squamous Cell Carcinoma. J Inflamm Res Liu C, Li H, Li H, Liu L, Liang J, Zhao Y, Shen S. PMID: 41767901 [PubMed]
	Construction and validation of a novel diagnostic model for esophageal squamous cell carcinoma: an integrated analysis of multi-omics data. Front Immunol Cui Y, Li S, Wu Z, Jin Y, Yu J, Chen Y, Chen J, Chang J, Yan Y, Li X, Li N, Hu S, Zhu C, Feng L. PMID: 41766902 [PubMed - indexed for MEDLINE]
	Construction of circadian clock signature for tumor microenvironment in predicting survival of esophageal squamous cell carcinoma. Front Immunol Xiang Y, Cui X, Cui Z. PMID: 41766897 [PubMed - in process]

Articles 1 - 20 / 38358

Page 1 de 1918



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité